Dan Wang

Prof. Dan Wang

Georgetown University
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2003 in Kidney International
Verified
Journal Article
Closed access
DWDan Wang
Dan Wang
JIJens Iversen
Jens Iversen
CWChristopher S. Wilcox
Christopher S. Wilcox
SSSvend Strandgaard
Svend Strandgaard

1 February 2008 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
DWDan Wang
Dan Wang
SSSvend Strandgaard
Svend Strandgaard
MBMalene L. Borresen
Malene L. Borresen
ZLZaiming Luo
Zaiming Luo
SCStephanie G. Connors
Stephanie G. Connors
CWChristopher S. Wilcox
Christopher S. Wilcox

1 December 2005 in Journal of Vascular Research
Verified
Journal Article
Closed access
DWDan Wang
Dan Wang
TCTina Chabrashvili
Tina Chabrashvili
LBLillian Borrego
Lillian Borrego
SAShakil Aslam
Shakil Aslam
JUJason G. Umans
Jason G. Umans
We hypothesized that prolonged angiotensin II (AngII) infusion would alter vascular reactivity by enhancing superoxide anion (O–·2) generation. Male C57BL/6 mice were infused with AngII at 400 ng/kg/min (n = 16, AngII mice) or vehicle (n = 16, sham mice) for 2 weeks via subcutaneous osmotic minipumps. Contraction and relaxation of mesenteric resistance vessels (MRVs) were assessed using a Mulvany-Halpern myograph. AngII infusion increased systolic blood pressure, MRV NADPH oxidase activity and expression of p22phox mRNA. Contraction to norepinephrine was unchanged, but AngII infusion increased contractile responses to AngII (41 ± 5 vs. 10 ± 4%, p < 0.001) and endothelin-1 (ET-1; 95 ± 10 vs. 70 ± 9%, p < 0.05), which was normalized by tempol (10–4 M, a stable membrane-permeable superoxide dismutase mimetic) and ebselen [10–5 M, a peroxynitrite (ONOO–) scavenger]. Endothelium removal enhanced MRV contraction to AngII and ET-1 in sham mice but blunted these contractile responses in AngII mice. Relaxation to ACh was impaired in AngII mice (60.1 ± 8.8 vs. 83.2 ± 3.5%, p < 0.01), which normalized by tempol, whereas relaxation to sodium nitroprusside was similar in both groups. N-nitro-L-arginine (NNLA, a nitric oxide synthase inhibitor), partially inhibited acetylcholine relaxation of vessels from sham mice but not from AngII mice. The residual endothelium-dependent hyperpolarizing-factor-like relaxation was not different between groups. In conclusion,the AngII slow pressor response in mouse MRVs consisted of specific contractile hyperresponsiveness and impairment in the NO-mediated component of endothelium-dependent relaxation, which was mediated by O–·2 and ONOO– in the vascular smooth muscle cell.

1 March 2004 in Hypertension
Verified
Journal Article
Closed access
CZChunyu Zeng
Chunyu Zeng
DWDan Wang
Dan Wang
LALaureano D. Asico
Laureano D. Asico
WWWilliam J. Welch
William J. Welch
CWChristopher S. Wilcox
Christopher S. Wilcox
PJPedro A. Jose
Pedro A. Jose
Dopamine plays a role in the regulation of blood pressure by inhibition of sodium transport in renal proximal tubules (RPTs) and relaxation of vascular smooth muscles. Because dopamine receptors can regulate and interact with each other, we studied the interaction of D 1 and D 3 receptors in immortalized RPT cells and mesenteric arteries from Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHRs), and in human coronary artery smooth muscle cells (CASMCs). In WKY rats, the D 1 -like agonist, fenoldopam, increased D 3 receptor protein in a time-dependent and concentration-dependent manner (EC 50 =4.5×10 −9 M, t 1/2 =15.8 hours). In SHRs, fenoldopam (10 −5 M) actually decreased the expression of D 3 receptors. D 1 and D 3 receptor co-immunoprecipitation was increased by fenoldopam (10 −7 M/24 h) in WKY rats but not in SHRs. The effects of fenoldopam in CASMCs were similar as those in WKY RPT cells (ie, fenoldopam increased D 1 and D 3 receptor proteins). Both D 3 (PD128907, Emax=80%±6%, pED 50 =5±0.1) and D 1 -like receptor (fenoldopam, Emax=81%±8%, pED 50 =5±0.2, n=12) agonists relaxed mesenteric arterial rings. Co-stimulation of D 1 and D 3 receptors led to additive vasorelaxation in WKY rats, but not in SHRs. D 1 and D 3 receptors interact differently in WKY and SHRs. Altered interactions between D 1 and D 3 receptors may play a role in the pathogenesis of genetic hypertension, including human hypertension, because these receptors also interact in human vascular smooth muscle cells.

22 June 2019 in Antioxidants
Verified
Journal Article
Open access
PDF file
CWChristopher S Wilcox
Christopher S Wilcox
Cheng WangCheng Wang
Cheng Wang
DWDan Wang
Dan Wang
(1) Background: Angiotensin II (Ang II) and endothelin 1 (ET-1) generate reactive oxygen species (ROS) that can activate cyclooxygenase (COX). However, thromboxane prostanoid receptors (TPRs) are required to increase systemic markers of ROS during Ang II infusion in mice. We hypothesized that COX and TPRs are upstream requirements for the generation of vascular ROS by ET-1. (2) Methods: ET-1-induced vascular contractions and ROS were assessed in mesenteric arterioles from wild type (+/+) and knockout (−/−) of COX1 or TPR mice infused with Ang II (400 ng/kg/min × 14 days) or a vehicle. (3) Results: Ang II infusion appeared to increase microvascular protein expression of endothelin type A receptors (ETARs), TPRs, and COX1 and 2 in COX1 and TPR +/+ mice but not in −/− mice. Ang II infusion increased ET-1-induced vascular contractions and ROS, which were prevented by a blockade of COX1 and 2 in TPR −/− mice. ET-1 increased the activity of aortic nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and decreased superoxide dismutase (SOD) 1, 2, and 3 in Ang-II-infused mice, which were prevented by a blockade of TPRs. (4) Conclusion: Activation of vascular TPRs by COX products are required for ET-1 to increase vascular contractions and ROS generation from NADPH oxidase and reduce ROS metabolism by SOD. These effects require an increase in these systems by prior infusion of Ang II.

1 May 2015 in Hypertension
Verified
Journal Article
Closed access
PDF file
CWCheng Wang
Cheng Wang
ZLZaiming Luo
Zaiming Luo
DKDonald Kohan
Donald Kohan
AWAnton Wellstein
Anton Wellstein
PJPedro A. Jose
Pedro A. Jose
DWDan Wang
Dan Wang
Cardiovascular disease is frequent in chronic kidney disease and has been related to angiotensin II, endothelin-1 (ET-1), thromboxane A2, and reactive oxygen species (ROS). Because activation of thromboxane prostanoid receptors (TP-Rs) can generate ROS, which can generate ET-1, we tested the hypothesis that chronic kidney disease induces cyclooxygenase-2 whose products activate TP-Rs to enhance ET-1 and ROS generation and contractions. Mesenteric resistance arterioles were isolated from C57/BL6 or TP-R+/+ and TP-R−/− mice 3 months after SHAM-operation (SHAM) or surgical reduced renal mass (RRM, n=6/group). Microvascular contractions were studied on a wire myograph. Cellular (ethidium: dihydroethidium) and mitochondrial (mitoSOX) ROS were measured by fluorescence microscopy. Mice with RRM had increased excretion of markers of oxidative stress, thromboxane, and microalbumin; increased plasma ET-1; and increased microvascular expression of p22phox, cyclooxygenase-2, TP-Rs, preproendothelin and endothelin-A receptors, and increased arteriolar remodeling. They had increased contractions to U-46,619 (118±3 versus 87±6,P<0.05) and ET-1 (108±5 versus 89±4,P<0.05), which were dependent on cellular and mitochondrial ROS, cyclooxygenase-2, and TP-Rs. RRM doubled the ET-1-induced cellular and mitochondrial ROS generation (P<0.05). TP-R−/− mice with RRM lacked these abnormal structural and functional microvascular responses and lacked the increased systemic and the increased microvascular oxidative stress and circulating ET-1. In conclusion, RRM leads to microvascular remodeling and enhanced ET-1-induced cellular and mitochondrial ROS and contractions that are mediated by cyclooxygenase-2 products activating TP-Rs. Thus, TP-Rs can be upstream from enhanced ROS, ET-1, microvascular remodeling, and contractility and may thereby coordinate vascular dysfunction in chronic kidney disease.